Walleye Capital LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Walleye Capital LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $3.48 Million - $4.28 Million	14,900 Added 2980.0%	15,400 $4.24 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $702,219 - $1.21 Million	-4,900 Reduced 90.74%	500 $121,000
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $395,577 - $535,140	2,700 Added 100.0%	5,400 $807,000
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $1.03 Million - $1.34 Million	-6,800 Reduced 71.58%	2,700 $516,000
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $1.25 Million - $1.55 Million	7,300 Added 331.82%	9,500 $1.68 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $943,551 - $1.08 Million	-5,100 Reduced 69.86%	2,200 $417,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $1.28 Million - $1.65 Million	7,000 Added 2333.33%	7,300 $1.46 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $55,659 - $72,393	300 New	300 $71,000
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $530,784 - $763,743	-5,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $357,648 - $596,304	4,800 Added 533.33%	5,700 $656,000
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $942,970 - $1.17 Million	-13,300 Reduced 93.66%	900 $72,000
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $329,300 - $463,950	5,000 Added 54.35%	14,200 $1.03 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $669,392 - $859,740	9,200 New	9,200 $860,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.